John Hamm
Impact in
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 42
- Lung Cancer Research Studies 10
- Cancer Treatment and Pharmacology 9
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 7
- Colorectal Cancer Treatments and Studies 6
- Pancreatic and Hepatic Oncology Research 6
-
- Lung Cancer Treatments and Mutations 9
- Co-authors
- J. Randolph Hecht (3 shared papers)Daniel de Castro (2 shared papers)Steven Gallinger (2 shared papers)Wendy R. Parulekar (2 shared papers)Arié Figer (2 shared papers)P. Murawa (2 shared papers)Robert Lim (2 shared papers)Malcolm J. Moore (2 shared papers)
- Journals
- Journal of Clinical Oncology (21 papers)Annals of Oncology (7 papers)Breast Cancer Research and Treatment (3 papers)Cancer (3 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
John Hamm
73 papers receiving 5.1k citations
John Hamm's Hit Papers
Peers
Comparison fields: 5 of 119
- Oncology 3.4k
- Cancer Research 951
- Pulmonary and Respiratory Medicine 1.1k
- Hepatology 189
- Biotechnology 178
Countries citing papers authored by John Hamm
This map shows the geographic impact of John Hamm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Hamm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Hamm more than expected).
Fields of papers citing papers by John Hamm
This network shows the impact of papers produced by John Hamm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Hamm. The network helps show where John Hamm may publish in the future.
Co-authors
The 25 scholars most cited alongside John Hamm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group Hit paper breakdown → | 2007 | 2920 |
| 2 | Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial Hit paper breakdown → | 2005 | 710 |
| 3 | 2003 | 301 | |
| 4 | 2022 | 108 | |
| 5 | 2013 | 104 | |
| 6 | 1991 | 91 | |
| 7 | 2004 | 70 | |
| 8 | 2009 | 54 | |
| 9 | 2013 | 49 | |
| 10 | 2020 | 48 | |
| 11 | 2021 | 45 | |
| 12 | 2012 | 43 | |
| 13 | 2023 | 41 | |
| 14 | 1994 | 40 | |
| 15 | 1983 | 40 | |
| 16 | 2013 | 38 | |
| 17 | 2012 | 35 | |
| 18 | 2018 | 34 | |
| 19 | 2019 | 34 | |
| 20 | 2011 | 30 |
About John Hamm
John Hamm is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Genetics and Cancer Research, having authored 75 papers that have together received 5.2k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (10 papers), Cancer Treatment and Pharmacology (9 papers), Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Cancer therapeutics and mechanisms (6 papers). The work is most often cited by research in Oncology (3.4k citations), Cancer Research (951 citations), Pulmonary and Respiratory Medicine (1.1k citations), Hepatology (189 citations) and Biotechnology (178 citations). John Hamm has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include J. Randolph Hecht, Daniel de Castro, Steven Gallinger, Wendy R. Parulekar, Arié Figer, P. Murawa, Robert Lim, Malcolm J. Moore, David Walde and David Goldstein. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Breast Cancer Research and Treatment, Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.